Immunovant (IMVT) PT Raised to $37 at Nomura/Instinet; 'Increasingly Derisked'
Tweet Send to a Friend
Nomura/Instinet analyst Christopher Marai raised the price target on Immunovant (NASDAQ: IMVT) to $37.00 (from $27.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
